TransCure bioServices
Carouge
About TransCure bioServices
TransCure bioServices has developped unique Research & Development (R&D) platforms, called the Humanized Immune System (HIS) and Human Immunodeficiency Virus (HIV) mouse models. They provide access to these platforms as a fee-for-service for the pharmaceutical companies, biotechs as well as academic laboratories which profile new drugs targeting immuno-related diseases and novel anti-HIV/AIDS therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $4.0M
- Funding stage: M&A
- Last round: Series Unknown (Jun 2019)
- Website: transcurebioservices.com
- Phone: 079 955 64 56
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/transcure-bioservices-10251 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.